董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Paul Glavine | 男 | Director and Chief Growth Officer | 34 | 未披露 | 未持股 | 2023-06-27 |
| Eric So | 男 | Director and President | 47 | 未披露 | 未持股 | 2023-06-27 |
| Theresa Firestone | 女 | Director | 67 | 未披露 | 未持股 | 2023-06-27 |
| Grant Froese | 男 | Director | 61 | 未披露 | 未持股 | 2023-06-27 |
| Eric Hoskins | 男 | Director | 62 | 未披露 | 未持股 | 2023-06-27 |
| Mark Lawson | 男 | Director | 50 | 未披露 | 未持股 | 2023-06-27 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Paul Glavine | 男 | Director and Chief Growth Officer | 34 | 未披露 | 未持股 | 2023-06-27 |
| Eric So | 男 | Director and President | 47 | 未披露 | 未持股 | 2023-06-27 |
| Douglas Drysdale | 男 | Chief Executive Officer | 53 | 未披露 | 未持股 | 2023-06-27 |
| Greg Cavers | -- | Chief Financial Officer | 53 | 未披露 | 未持股 | 2023-06-27 |
| Gabriel Fahel | 男 | Chief Legal Officer | 48 | 未披露 | 未持股 | 2023-06-27 |
董事简历
中英对照 | 中文 | 英文- Paul Glavine
-
Paul Glavine是该公司的联合创始人和首席运营官。他是一位连续创业者和投资者，在生物技术、采矿、技术和生命科学领域拥有丰富的经验。Glavine先生是TruVerra的联合创始人，该公司被Supreme Cannabis Company收购，后来又被Canopy Growth收购。他之前的背景是从事停车技术行业，过去5年间，他曾为1.8亿人次的并购及其他融资提供咨询服务。
Paul Glavine,is a Co-founder and the Chief Operating Officer of the Company. He is a serial entrepreneur and investor with vast experience in the biotech, mining, tech and life science sectors. Mr. Glavine is the Co-founder of TruVerra, which was acquired by Supreme Cannabis Company, and later acquired by Canopy Growth. His previous background is in the parking technology industry and he has advised on M&A and other financings in accesses of 180M in the past 5 years. - Paul Glavine是该公司的联合创始人和首席运营官。他是一位连续创业者和投资者，在生物技术、采矿、技术和生命科学领域拥有丰富的经验。Glavine先生是TruVerra的联合创始人，该公司被Supreme Cannabis Company收购，后来又被Canopy Growth收购。他之前的背景是从事停车技术行业，过去5年间，他曾为1.8亿人次的并购及其他融资提供咨询服务。
- Paul Glavine,is a Co-founder and the Chief Operating Officer of the Company. He is a serial entrepreneur and investor with vast experience in the biotech, mining, tech and life science sectors. Mr. Glavine is the Co-founder of TruVerra, which was acquired by Supreme Cannabis Company, and later acquired by Canopy Growth. His previous background is in the parking technology industry and he has advised on M&A and other financings in accesses of 180M in the past 5 years.
- Eric So
-
Eric So是该公司的联合创始人和总裁。在过去15年中，他是各种公共和私营公司的资深所有者和经营者，并在从初创企业到高增长和跨国企业的商业生命周期的各个阶段领导C级公司战略、发展和财务。他的职业生涯始于Torys LLP的公司商业、证券、金融和并购领域。
Eric So,is a Co-founder and President of the Company. He is a veteran owner and operator of various public and private companies over the last 15 years and has led C-level corporate strategy, development and finance at all stages of the business life cycle from start-up to high growth and multinational. He began his career practicing in the areas of corporate commercial, securities, finance and mergers and acquisitions at Torys LLP. - Eric So是该公司的联合创始人和总裁。在过去15年中，他是各种公共和私营公司的资深所有者和经营者，并在从初创企业到高增长和跨国企业的商业生命周期的各个阶段领导C级公司战略、发展和财务。他的职业生涯始于Torys LLP的公司商业、证券、金融和并购领域。
- Eric So,is a Co-founder and President of the Company. He is a veteran owner and operator of various public and private companies over the last 15 years and has led C-level corporate strategy, development and finance at all stages of the business life cycle from start-up to high growth and multinational. He began his career practicing in the areas of corporate commercial, securities, finance and mergers and acquisitions at Torys LLP.
- Theresa Firestone
-
Theresa Firestone是一位资深医疗保健高管，拥有零售、制药、健康和保健、政府和全球重组方面的专业知识。她在辉瑞公司担任了15年的高级职务，在政府部门工作了14年，在零售和保健部门工作了7年。Firestone女士拥有在加拿大、欧洲和亚洲担任行政领导职务的国际经验和丰富的损益表经验。在辉瑞，费尔斯通女士是亚洲新兴市场区域总裁，负责1.4B美元的损益表，并负责管理亚洲的9个市场。费尔斯通女士最近担任Shoppers Drug Mart的高级副总裁，负责领导健康和保健计划，包括新的增长战略以及健康诊所和PC Health App的开发和推出。
Theresa Firestone,is a senior healthcare executive with retail, pharmaceutical, health & wellness, government and global restructuring expertise. She spent 15 years in senior roles at Pfizer Inc., 14 years in government and 7 years in the retail and health and wellness sector. Ms. Firestone has international experience in executive leadership roles in Canada, Europe and Asia and extensive P&L experience. At Pfizer, Ms. Firestone was Regional President of Emerging Markets Asia and had responsibility for a P&L of $1.4B and oversaw 9 markets in Asia. Ms. Firestone was most recently Senior Vice President with Shoppers Drug Mart where she lead the health and wellness initiatives including new growth strategies and the development and launch of health clinics and the PC Health App. - Theresa Firestone是一位资深医疗保健高管，拥有零售、制药、健康和保健、政府和全球重组方面的专业知识。她在辉瑞公司担任了15年的高级职务，在政府部门工作了14年，在零售和保健部门工作了7年。Firestone女士拥有在加拿大、欧洲和亚洲担任行政领导职务的国际经验和丰富的损益表经验。在辉瑞，费尔斯通女士是亚洲新兴市场区域总裁，负责1.4B美元的损益表，并负责管理亚洲的9个市场。费尔斯通女士最近担任Shoppers Drug Mart的高级副总裁，负责领导健康和保健计划，包括新的增长战略以及健康诊所和PC Health App的开发和推出。
- Theresa Firestone,is a senior healthcare executive with retail, pharmaceutical, health & wellness, government and global restructuring expertise. She spent 15 years in senior roles at Pfizer Inc., 14 years in government and 7 years in the retail and health and wellness sector. Ms. Firestone has international experience in executive leadership roles in Canada, Europe and Asia and extensive P&L experience. At Pfizer, Ms. Firestone was Regional President of Emerging Markets Asia and had responsibility for a P&L of $1.4B and oversaw 9 markets in Asia. Ms. Firestone was most recently Senior Vice President with Shoppers Drug Mart where she lead the health and wellness initiatives including new growth strategies and the development and launch of health clinics and the PC Health App.
- Grant Froese
-
格兰特弗罗斯在加拿大零售巨头Loblaw Companies Limited完成了38年的职业生涯，他最后一次担任首席运营官直到退休。在Loblaw的职业生涯中，他领导运营、销售，并监督供应链、电子商务和营销职能。最近，格兰特是Harvest One的首席执行官。格兰特是灰狼管理服务公司的首席顾问，也是多家公司的董事会成员。
Grant Froese,completed a 38-year career with Canadian retail giant Loblaw Companies Limited where he last served as Chief Operating Officer until his retirement. During his career at Loblaw, he led operations, merchandising and had oversight of supply chain, ecommerce, and marketing functions. Most recently, Grant was the CEO of Harvest One. Grant is the principal consultant at Grey Wolf Management Services Inc. and sits on the board of several companies. - 格兰特弗罗斯在加拿大零售巨头Loblaw Companies Limited完成了38年的职业生涯，他最后一次担任首席运营官直到退休。在Loblaw的职业生涯中，他领导运营、销售，并监督供应链、电子商务和营销职能。最近，格兰特是Harvest One的首席执行官。格兰特是灰狼管理服务公司的首席顾问，也是多家公司的董事会成员。
- Grant Froese,completed a 38-year career with Canadian retail giant Loblaw Companies Limited where he last served as Chief Operating Officer until his retirement. During his career at Loblaw, he led operations, merchandising and had oversight of supply chain, ecommerce, and marketing functions. Most recently, Grant was the CEO of Harvest One. Grant is the principal consultant at Grey Wolf Management Services Inc. and sits on the board of several companies.
- Eric Hoskins
-
埃里克霍斯金斯是Maverix Private Equity的合伙人。他是安大略省前卫生部长（2014-2018年），负责北美最大的医疗保健系统之一。他曾是安大略省议会的民选议员，在卫生、经济发展和贸易、儿童和青年服务以及移民等领域担任内阁职务。霍斯金斯博士是一名医生和公共卫生专家，在卫生保健和公共政策方面拥有30多年的经验。
Eric Hoskins,is a Partner at Maverix Private Equity. He is the former Ontario Health Minister (2014-2018) responsible for one of the largest health care systems in North America. He is a former elected Member of Ontario Provincial Parliament holding Cabinet positions in Health, Economic Development and Trade, Children and Youth Services, and Immigration. Dr. Hoskins is a physician and public health specialist with more than thirty years' experience in health care and public policy. - 埃里克霍斯金斯是Maverix Private Equity的合伙人。他是安大略省前卫生部长（2014-2018年），负责北美最大的医疗保健系统之一。他曾是安大略省议会的民选议员，在卫生、经济发展和贸易、儿童和青年服务以及移民等领域担任内阁职务。霍斯金斯博士是一名医生和公共卫生专家，在卫生保健和公共政策方面拥有30多年的经验。
- Eric Hoskins,is a Partner at Maverix Private Equity. He is the former Ontario Health Minister (2014-2018) responsible for one of the largest health care systems in North America. He is a former elected Member of Ontario Provincial Parliament holding Cabinet positions in Health, Economic Development and Trade, Children and Youth Services, and Immigration. Dr. Hoskins is a physician and public health specialist with more than thirty years' experience in health care and public policy.
- Mark Lawson
-
马克·劳森是一位私人股本和投资银行高管，在加拿大、美国和新兴市场拥有超过20年的经验。他目前是Invert公司的碳收购主管，该公司为全球碳减排和碳清除项目提供资金，并正在建立一个平台，将抗击气候变化的力量掌握在你手中。从2008年至今，劳森先生一直担任Clermont Capital Partners的管理合伙人。Clermont Capital Partners是一家总部位于多伦多的商业银行和咨询公司，专注于技术和医疗保健领域。从2004年到2008年，他在纽约的摩根士丹利担任投资银行家，参与了医疗保健、科技和电信领域价值超过60亿美元的并购、80亿美元的债券发行和5亿美元的股权融资。劳森目前还是北美多家上市公司的董事。Lawson先生在加拿大西安大略大学获得统计科学文学士学位，在加拿大西安大略大学Richard Ivey商学院获得MBA学位。劳森先生是纽约经济俱乐部的成员，也是休和伊莱娜·劳森慈善组织的主任。
Mark Lawson,is a private equity and investment banking executive with over 20 years of experience in Canada, the United States, and in the emerging markets. He is currently the Head of Carbon Acquisition for Invert, a company that funds global carbon reduction and removal projects, and is building a platform that puts the power to fight climate change in your hands. From 2008 to present Mr. Lawson has been the Managing Partner of Clermont Capital Partners, a Toronto based merchant bank and advisory firm focused on the technology and healthcare sectors. From 2004 to 2008 he was an investment banker with Morgan Stanley in New York, where he was involved in the execution of over $6 billion worth of mergers and acquisitions, $8 billion worth of debt offerings and $500 million of equity financings in the healthcare, technology, and telecom sectors. Mr. Lawson is also currently a director of various publicly traded companies in North America. Mr. Lawson received his Bachelor of Arts in Statistical Sciences from The University of Western Ontario, Canada and his MBA from The Richard Ivey School of Business, University of Western Ontario, Canada. Mr. Lawson is a member of the Economic Club of New York and is a Director of the Hugh and Ilene Lawson Charitable Organization. - 马克·劳森是一位私人股本和投资银行高管，在加拿大、美国和新兴市场拥有超过20年的经验。他目前是Invert公司的碳收购主管，该公司为全球碳减排和碳清除项目提供资金，并正在建立一个平台，将抗击气候变化的力量掌握在你手中。从2008年至今，劳森先生一直担任Clermont Capital Partners的管理合伙人。Clermont Capital Partners是一家总部位于多伦多的商业银行和咨询公司，专注于技术和医疗保健领域。从2004年到2008年，他在纽约的摩根士丹利担任投资银行家，参与了医疗保健、科技和电信领域价值超过60亿美元的并购、80亿美元的债券发行和5亿美元的股权融资。劳森目前还是北美多家上市公司的董事。Lawson先生在加拿大西安大略大学获得统计科学文学士学位，在加拿大西安大略大学Richard Ivey商学院获得MBA学位。劳森先生是纽约经济俱乐部的成员，也是休和伊莱娜·劳森慈善组织的主任。
- Mark Lawson,is a private equity and investment banking executive with over 20 years of experience in Canada, the United States, and in the emerging markets. He is currently the Head of Carbon Acquisition for Invert, a company that funds global carbon reduction and removal projects, and is building a platform that puts the power to fight climate change in your hands. From 2008 to present Mr. Lawson has been the Managing Partner of Clermont Capital Partners, a Toronto based merchant bank and advisory firm focused on the technology and healthcare sectors. From 2004 to 2008 he was an investment banker with Morgan Stanley in New York, where he was involved in the execution of over $6 billion worth of mergers and acquisitions, $8 billion worth of debt offerings and $500 million of equity financings in the healthcare, technology, and telecom sectors. Mr. Lawson is also currently a director of various publicly traded companies in North America. Mr. Lawson received his Bachelor of Arts in Statistical Sciences from The University of Western Ontario, Canada and his MBA from The Richard Ivey School of Business, University of Western Ontario, Canada. Mr. Lawson is a member of the Economic Club of New York and is a Director of the Hugh and Ilene Lawson Charitable Organization.
高管简历
中英对照 | 中文 | 英文- Paul Glavine
Paul Glavine是该公司的联合创始人和首席运营官。他是一位连续创业者和投资者，在生物技术、采矿、技术和生命科学领域拥有丰富的经验。Glavine先生是TruVerra的联合创始人，该公司被Supreme Cannabis Company收购，后来又被Canopy Growth收购。他之前的背景是从事停车技术行业，过去5年间，他曾为1.8亿人次的并购及其他融资提供咨询服务。
Paul Glavine,is a Co-founder and the Chief Operating Officer of the Company. He is a serial entrepreneur and investor with vast experience in the biotech, mining, tech and life science sectors. Mr. Glavine is the Co-founder of TruVerra, which was acquired by Supreme Cannabis Company, and later acquired by Canopy Growth. His previous background is in the parking technology industry and he has advised on M&A and other financings in accesses of 180M in the past 5 years.- Paul Glavine是该公司的联合创始人和首席运营官。他是一位连续创业者和投资者，在生物技术、采矿、技术和生命科学领域拥有丰富的经验。Glavine先生是TruVerra的联合创始人，该公司被Supreme Cannabis Company收购，后来又被Canopy Growth收购。他之前的背景是从事停车技术行业，过去5年间，他曾为1.8亿人次的并购及其他融资提供咨询服务。
- Paul Glavine,is a Co-founder and the Chief Operating Officer of the Company. He is a serial entrepreneur and investor with vast experience in the biotech, mining, tech and life science sectors. Mr. Glavine is the Co-founder of TruVerra, which was acquired by Supreme Cannabis Company, and later acquired by Canopy Growth. His previous background is in the parking technology industry and he has advised on M&A and other financings in accesses of 180M in the past 5 years.
- Eric So
Eric So是该公司的联合创始人和总裁。在过去15年中，他是各种公共和私营公司的资深所有者和经营者，并在从初创企业到高增长和跨国企业的商业生命周期的各个阶段领导C级公司战略、发展和财务。他的职业生涯始于Torys LLP的公司商业、证券、金融和并购领域。
Eric So,is a Co-founder and President of the Company. He is a veteran owner and operator of various public and private companies over the last 15 years and has led C-level corporate strategy, development and finance at all stages of the business life cycle from start-up to high growth and multinational. He began his career practicing in the areas of corporate commercial, securities, finance and mergers and acquisitions at Torys LLP.- Eric So是该公司的联合创始人和总裁。在过去15年中，他是各种公共和私营公司的资深所有者和经营者，并在从初创企业到高增长和跨国企业的商业生命周期的各个阶段领导C级公司战略、发展和财务。他的职业生涯始于Torys LLP的公司商业、证券、金融和并购领域。
- Eric So,is a Co-founder and President of the Company. He is a veteran owner and operator of various public and private companies over the last 15 years and has led C-level corporate strategy, development and finance at all stages of the business life cycle from start-up to high growth and multinational. He began his career practicing in the areas of corporate commercial, securities, finance and mergers and acquisitions at Torys LLP.
- Douglas Drysdale
Douglas Drysdale是公司的首席执行官。Drysdale先生在医疗保健领域有30多年的经验。作为一名娴熟的企业董事，德赖斯代尔在2014年初领导了纳斯达克上市的制药公司Pernix Therapeutics Inc.的资本重组，筹集了6500万美元。在担任董事长兼首席执行官的第一年内，德赖斯代尔先生重建了管理团队和董事会，并建立了一个220人的销售团队，包括配套职能（市场营销、销售培训、销售运营和分析）。德赖斯代尔的努力使公司的企业价值从8000万美元成倍增长到了8亿美元左右。在德赖斯代尔的领导下，这家制药公司筹集了4.65亿美元的资金。2008年，德赖斯代尔还是Alvogen的创始首席执行官，带领公司从一开始就扩张到35个国家，在5年内实现了约500美元的收入。在其职业生涯的早期，德赖斯代尔曾担任阿特维斯集团的并购主管，在2004年至2008年期间领导了三大洲的15宗企业收购，其中包括在中东欧进行的一次引人注目的公开敌意收购。在此期间，德赖斯代尔筹集了大约30亿美元的资金，并管理包括25多家银行在内的贷款辛迪加，为其发展提供资金。阿特维斯在2012年以42.5亿欧元的价格卖给了华森制药。
Douglas Drysdale,is the Chief Executive Officer of the Company. Mr. Drysdale has more than 30 years of experience in the health care sector. As a skillful corporate director, in early 2014, Mr. Drysdale led the recapitalization of a NASDAQ-listed pharmaceutical company, Pernix Therapeutics Inc., raising $65 million. Within the first year of taking the helm as Chairman and CEO, Mr. Drysdale rebuilt the management team and board of directors, and built a 220-person sales team, complete with supporting functions (marketing, sales training, sales operations, and analytics). Mr. Drysdale's efforts grew the company's enterprise value exponentially from $80 million to around $800 million. Under Mr. Drysdale's leadership, the pharmaceutical company raised $465 million of capital. Mr. Drysdale was also the founding CEO of Alvogen in 2008, leading the company from inception through an expansion to 35 countries and revenues of approx $500mm in 5 years. Earlier in his career, Mr. Drysdale served as Head of M&A at Actavis Group, leading 15 corporate acquisitions across three continents, between 2004 and 2008, including a high-profile public hostile takeover attempt in Central Eastern Europe. Over this period, Mr. Drysdale raised approximately $3 billion of capital and managed lending syndicates, including over 25 banks, to fund its growth. Actavis was sold to Watson Pharmaceuticals in 2012 for EUR 4.25 billion . Mr. Drysdale received a Bachelor of Science degree from University of East Anglia, UK in Biological Sciences.- Douglas Drysdale是公司的首席执行官。Drysdale先生在医疗保健领域有30多年的经验。作为一名娴熟的企业董事，德赖斯代尔在2014年初领导了纳斯达克上市的制药公司Pernix Therapeutics Inc.的资本重组，筹集了6500万美元。在担任董事长兼首席执行官的第一年内，德赖斯代尔先生重建了管理团队和董事会，并建立了一个220人的销售团队，包括配套职能（市场营销、销售培训、销售运营和分析）。德赖斯代尔的努力使公司的企业价值从8000万美元成倍增长到了8亿美元左右。在德赖斯代尔的领导下，这家制药公司筹集了4.65亿美元的资金。2008年，德赖斯代尔还是Alvogen的创始首席执行官，带领公司从一开始就扩张到35个国家，在5年内实现了约500美元的收入。在其职业生涯的早期，德赖斯代尔曾担任阿特维斯集团的并购主管，在2004年至2008年期间领导了三大洲的15宗企业收购，其中包括在中东欧进行的一次引人注目的公开敌意收购。在此期间，德赖斯代尔筹集了大约30亿美元的资金，并管理包括25多家银行在内的贷款辛迪加，为其发展提供资金。阿特维斯在2012年以42.5亿欧元的价格卖给了华森制药。
- Douglas Drysdale,is the Chief Executive Officer of the Company. Mr. Drysdale has more than 30 years of experience in the health care sector. As a skillful corporate director, in early 2014, Mr. Drysdale led the recapitalization of a NASDAQ-listed pharmaceutical company, Pernix Therapeutics Inc., raising $65 million. Within the first year of taking the helm as Chairman and CEO, Mr. Drysdale rebuilt the management team and board of directors, and built a 220-person sales team, complete with supporting functions (marketing, sales training, sales operations, and analytics). Mr. Drysdale's efforts grew the company's enterprise value exponentially from $80 million to around $800 million. Under Mr. Drysdale's leadership, the pharmaceutical company raised $465 million of capital. Mr. Drysdale was also the founding CEO of Alvogen in 2008, leading the company from inception through an expansion to 35 countries and revenues of approx $500mm in 5 years. Earlier in his career, Mr. Drysdale served as Head of M&A at Actavis Group, leading 15 corporate acquisitions across three continents, between 2004 and 2008, including a high-profile public hostile takeover attempt in Central Eastern Europe. Over this period, Mr. Drysdale raised approximately $3 billion of capital and managed lending syndicates, including over 25 banks, to fund its growth. Actavis was sold to Watson Pharmaceuticals in 2012 for EUR 4.25 billion . Mr. Drysdale received a Bachelor of Science degree from University of East Anglia, UK in Biological Sciences.
- Greg Cavers
Greg Cavers拥有不同成长阶段的服务运营经验；领导业务部门的初创企业、重组、系统实施和合并整合，同时提高盈利能力，将风险降至最低，致力于满足财务报告、国际财务报告准则，以及监管报告、OSFI和MFDA的要求。
Greg Cavers,has experience in service operations in varying stages of growth; leading business unit start-ups, restructuring, system implementations and merger integrations while increasing profitability, minimizing risk and dedicated to meeting financial reporting, IFRS; as well as regulatory reporting OSFI, MFDA requirements.- Greg Cavers拥有不同成长阶段的服务运营经验；领导业务部门的初创企业、重组、系统实施和合并整合，同时提高盈利能力，将风险降至最低，致力于满足财务报告、国际财务报告准则，以及监管报告、OSFI和MFDA的要求。
- Greg Cavers,has experience in service operations in varying stages of growth; leading business unit start-ups, restructuring, system implementations and merger integrations while increasing profitability, minimizing risk and dedicated to meeting financial reporting, IFRS; as well as regulatory reporting OSFI, MFDA requirements.
- Gabriel Fahel
Gabriel Fahel拥有在快节奏和充满政治色彩的环境中管理多司法管辖区和多学科团队的广泛经验。他参与了国际法的复杂和棘手的领域，并在加拿大各级法院，包括加拿大最高法院提出了新颖的法律问题。Fahel以前是加拿大政府的法律顾问，Mundo Media Ltd.和Growpacker Inc.的总法律顾问，并担任Adam Smith International和联合国开发计划署的法律顾问。在担任这些职务之前，Fahel先生是湾街律师事务所的一名律师，从事商业诉讼和公共利益集体诉讼。他是PsyCan（The Canadian Psychedelic Businesses Association）的创始董事。他在约克大学获得文学士学位（1997年），在温莎大学法学院获得法律学士学位（2000年），在纽约大学法学院获得法律硕士学位（2002年）。
Gabriel Fahel,has a broad range of experience managing multijurisdictional and multidisciplinary teams in fast-paced and politically charged environments. He has been engaged in complex and intractable areas of international law and advanced novel legal issues of law before every level of court in Canada, including the Supreme Court of Canada.Mr. Fahel was previously legal counsel with the Canadian government, General Counsel at Mundo Media Ltd. and Growpacker Inc., and served as legal advisor with Adam Smith International and the United Nations Development Programme. Prior to these positions, Mr. Fahel was a lawyer at Bay Street law firms engaged in commercial litigation and public interest class actions. He is a founding board member of PsyCan (The Canadian Psychedelic Businesses Association). He earned a Bachelor of Arts from York University (1997), a Bachelor of Laws from the University of Windsor, Faculty of Law (2000), and a Master of Laws from New York University School of Law (2002).- Gabriel Fahel拥有在快节奏和充满政治色彩的环境中管理多司法管辖区和多学科团队的广泛经验。他参与了国际法的复杂和棘手的领域，并在加拿大各级法院，包括加拿大最高法院提出了新颖的法律问题。Fahel以前是加拿大政府的法律顾问，Mundo Media Ltd.和Growpacker Inc.的总法律顾问，并担任Adam Smith International和联合国开发计划署的法律顾问。在担任这些职务之前，Fahel先生是湾街律师事务所的一名律师，从事商业诉讼和公共利益集体诉讼。他是PsyCan（The Canadian Psychedelic Businesses Association）的创始董事。他在约克大学获得文学士学位（1997年），在温莎大学法学院获得法律学士学位（2000年），在纽约大学法学院获得法律硕士学位（2002年）。
- Gabriel Fahel,has a broad range of experience managing multijurisdictional and multidisciplinary teams in fast-paced and politically charged environments. He has been engaged in complex and intractable areas of international law and advanced novel legal issues of law before every level of court in Canada, including the Supreme Court of Canada.Mr. Fahel was previously legal counsel with the Canadian government, General Counsel at Mundo Media Ltd. and Growpacker Inc., and served as legal advisor with Adam Smith International and the United Nations Development Programme. Prior to these positions, Mr. Fahel was a lawyer at Bay Street law firms engaged in commercial litigation and public interest class actions. He is a founding board member of PsyCan (The Canadian Psychedelic Businesses Association). He earned a Bachelor of Arts from York University (1997), a Bachelor of Laws from the University of Windsor, Faculty of Law (2000), and a Master of Laws from New York University School of Law (2002).